Repeat expansions confer WRN dependence in microsatellite-unstable cancers
The RecQ DNA helicase WRN is a synthetic lethal target for cancer cells with microsatellite instability (MSI), a form of genetic hypermutability that arises from impaired mismatch repair 1 – 4 . Depletion of WRN induces widespread DNA double-strand breaks in MSI cells, leading to cell cycle arrest a...
Saved in:
Published in | Nature (London) Vol. 586; no. 7828; pp. 292 - 298 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
08.10.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The RecQ DNA helicase WRN is a synthetic lethal target for cancer cells with microsatellite instability (MSI), a form of genetic hypermutability that arises from impaired mismatch repair
1
–
4
. Depletion of WRN induces widespread DNA double-strand breaks in MSI cells, leading to cell cycle arrest and/or apoptosis. However, the mechanism by which WRN protects MSI-associated cancers from double-strand breaks remains unclear. Here we show that TA-dinucleotide repeats are highly unstable in MSI cells and undergo large-scale expansions, distinct from previously described insertion or deletion mutations of a few nucleotides
5
. Expanded TA repeats form non-B DNA secondary structures that stall replication forks, activate the ATR checkpoint kinase, and require unwinding by the WRN helicase. In the absence of WRN, the expanded TA-dinucleotide repeats are susceptible to cleavage by the MUS81 nuclease, leading to massive chromosome shattering. These findings identify a distinct biomarker that underlies the synthetic lethal dependence on WRN, and support the development of therapeutic agents that target WRN for MSI-associated cancers.
In cells with microsatellite instability, expanded TA-dinucleotide repeats form cruciform structures that stall replication forks and cause chromosome shattering in the absence of the WRN helicase. |
---|---|
Bibliography: | Author contributions N.v.W. set up the project, performed END-seq and flow cytometry experiments upon WRN, MUS81 and SLX4 depletion, and performed preliminary analysis of END-seq data; W.J.N. performed MUS81–EME1 in situ END-seq and PCR; A.T. performed END-seq, Southern blotting and designed ATR-mutant WRN cDNA; E.M.C. generated the inducible WRN shRNA in KM12 and HCT116 cells, performed and analysed the HSEC western blot and viability experiments, long-read sequencing, and analysed the CCLE and WRN dependency data; E.C. performed ATRi END-seq experiments, western blotting, and metaphase analysis. V.T. performed RPA ChIP–seq; K. Foster performed the HSEC and long-read sequencing experiments; N.W. performed western blotting and helped to generate WRN(3A) and WRN(6A) cells; J.N. and J.K. analysed the CCLE and WRN dependency data; S.S. analysed END-seq, RPA ChIP–seq experiments; W.W. analysed WGS, PacBio coverage across repeats, deletion breakpoints in MSI cancers, and performed quantitative modeling; F.B. analysed nucleotide composition of broken versus non-broken repeats and replication timing; E.D. performed ExpansionHunter and exSTRa bioinformatic analysis; M.A.E. supervised computational work; K.G., Y.H., A.A.B., J.T.S. and N.K. analysed the data and designed bioinformatic pipelines; R.L.W. prepared WGS libraries; A.C.-M. and K. Fugger provided recombinant MUS81–EME1; J.A.S. provided recombinant WRN; B.E.H. provided advice about PCR across repeats; K.U. provided advice about repeat expansion biology; C.H.F. provided advice about secondary structure biology; R.M.B. provided advice about WRN helicase; S.C.W. provided advice about structure specific nucleases and recombination intermediates; P.J.M. helped design in situ experiments with recombinant proteins; P.S.M. provided advice on WGS experiments and analyses; A.J.B. and A.N. supervised the project; N.v.W., W.J.N., A.T., E.M.C., A.J.B. and A.N. wrote the manuscript with comments from the other authors. N.v.W., S.S., W.J.N., A.T. and E.M.C. contributed equally; E.C. and W.W. contributed equally as second authors. |
ISSN: | 0028-0836 1476-4687 |
DOI: | 10.1038/s41586-020-2769-8 |